Radiologic features of radiolucent foreign bodies ingestion in common mynah (Acridotheres tristis).

BACKGROUND In mynahs with foreign body ingestion, delayed diagnosis increases the risk of poor outcomes. OBJECTIVE The aim of this study was to evaluate various radiologic features on plain and contrast radiographs in mynahs for assessing the presence of ingested foreign bodies. METHODS In our cross-sectional study, a total of 41 mynahs were included. The diagnosis was made by history, surgery, excision by forceps or excretion in the faeces. Overall, 21 mynahs were considered not to have a foreign body in their gastrointestinal tract. Plain and post-contrast [oral administration of barium sulphate colloidal suspension of 25% weight/volume (20 mg/kg)] lateral and ventrodorsal radiographs from the cervical and coelomic cavity were taken. Different parameters including oesophageal, proventricular, and small intestinal diameters and opacities were assessed. Image evaluation was performed by two national board-certified radiologists blinded to the final diagnoses. RESULTS The inter- and intra-observer reliabilities of the diagnostic features were significant (p < 0.001). The diagnosis of the foreign body was highly accurate [90.2% (95% CI: 76.9%, 92.3%)] with the sensitivity, specificity, and area under the representative characteristic curve of 90.0%, 90.5%, and 0.93%, respectively for plain radiographs. The size and opacity of the oesophagus, proventriculus, and intestinal loops as well as serosal details were significantly different between mynahs with and without foreign body intake (p < 0.05). CONCLUSIONS Lateral and ventrodorsal plain radiographs are highly reliable for diagnosing the presence of non-opaque obstructing objects in the gastrointestinal tract of mynahs. Attention should be paid to the size and opacity of the oesophagus, extension, and opacity of the proventriculus, segmental opacity of intestinal loops, and decrease in serosal details

Removal of Microorganisms by UVC Radiation From the Air of Hospital

Currently, UVC radiation is used in hospitals to eliminate microorganisms and reduce adverse health effects in operating rooms (ORs) and protective environment rooms (PERs). The purpose of this study was to investigate the effect of UVC irradiation on bioaerosols in ORs and PERs. This experimental study was performed in ORs and PERs in a hospital. Bioaerosols were evaluated according to the National Institute for Occupational Safety and Health (NIOSH) standard (No. 0800). The samples were collected from indoor air of rooms before irradiation and after UVC(254 nm) irradiation for 20 and 480 minutes. The sample size of the study was determined to be 432 (216 fungi and 216 bacteria). The difference between the mean concentration of bioaerosols in the UVC radiation at two intervals (20 and 480 minutes) was significant, which indicates a decrease in the concentration of bioaerosols by increasing the duration of UVC radiation. Some bacteria, such as group B Streptococcus, Lactobacillus, and Listeria, were entirely killed after 20 minutes of irradiation; however, complete removal of the bacteria such as Staphylococcus pneumoniae and Staphylococcus saprophyticus was observed after 480 minutes of UVC irradiation. Fungi, such as Alternaria, Stofelim, and Mucor had a 100% reduction after 20 minutes of UVC irradiation, and Rhizopus and Aspergillus fumigatus showed a 100% decrease after 480 minutes of UVC irradiation. Other isolated fungi such as Cladosporium, Penicillium, Aspergillus niger, Rhodotorula, and Alternaria showed a decrease of 75%-98.78%. The ultraviolet (UV) sensitivity of bacterial and fungal bioaerosols depends strongly on their type. The results from this study may offer an important understanding of the control of indoor bioaerosols using UVC irradiation and help abate the environmental impacts of airborne microbes

Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

Funding: F Carvalho and E Fernandes acknowledge support from Fundação para a Ciência e a Tecnologia, I.P. (FCT), in the scope of the project UIDP/04378/2020 and UIDB/04378/2020 of the Research Unit on Applied Molecular Biosciences UCIBIO and the project LA/P/0140/2020 of the Associate Laboratory Institute for Health and Bioeconomy i4HB; FCT/MCTES through the project UIDB/50006/2020. J Conde acknowledges the European Research Council Starting Grant (ERC-StG-2019-848325). V M Costa acknowledges the grant SFRH/BHD/110001/2015, received by Portuguese national funds through Fundação para a Ciência e Tecnologia (FCT), IP, under the Norma Transitória DL57/2016/CP1334/CT0006.proofepub_ahead_of_prin

Primary Diffuse Large Cell Lymphoma of the Bladder: Case Report and Literature Review

Most bladder tumors are epithelial in origin. Nonepithelial cancers are rarely located in the bladder. Sarcomas are the most common malignancies among nonepithelial cancers. Primary bladder lymphoma is rare and mostly low grade. Here, we have reported a case of diffuse large cell lymphoma of the bladder. The patient, a 64-year-old man, had urinary frequency for 18 months. Abdominal sonography indicated a thick bladder wall and transurethral biopsy showed diffuse large cell lymphoma. Immunohistochemistry (IHC) results showed that the tumor was positive for CD20, CD45, and Pax-5 and negative for BCL-2, cytokeratin, and S100. He had a normal bone marrow biopsy, abdominal, pelvic and chest CT scans. He had no B symptoms. The patient received 6 cycles of R-CHOP followed by radiotherapy (36 Gy) to the pelvis. Six months after treatment, the patient is well and has returned to work. We have searched PubMed for primary diffuse large cell lymphoma. Primary diffuse large cell lymphoma of the bladder is best treated according to treatment for diffuse large cell lymphoma of other sites, which includes chemotherapy and radiotherapy. As seen in our review, primary diffuse large cell lymphoma of the bladder has a similar clinical course to diffuse large cell lymphoma of other sites

Outcomes after perioperative SARS-CoV-2 infection in patients with proximal femoral fractures: an international cohort study

Objectives Studies have demonstrated high rates of mortality in people with proximal femoral fracture and SARS-CoV-2, but there is limited published data on the factors that influence mortality for clinicians to make informed treatment decisions. This study aims to report the 30-day mortality associated with perioperative infection of patients undergoing surgery for proximal femoral fractures and to examine the factors that influence mortality in a multivariate analysis. Setting Prospective, international, multicentre, observational cohort study. Participants Patients undergoing any operation for a proximal femoral fracture from 1 February to 30 April 2020 and with perioperative SARS-CoV-2 infection (either 7 days prior or 30-day postoperative). Primary outcome 30-day mortality. Multivariate modelling was performed to identify factors associated with 30-day mortality. Results This study reports included 1063 patients from 174 hospitals in 19 countries. Overall 30-day mortality was 29.4% (313/1063). In an adjusted model, 30-day mortality was associated with male gender (OR 2.29, 95% CI 1.68 to 3.13, p80 years (OR 1.60, 95% CI 1.1 to 2.31, p=0.013), preoperative diagnosis of dementia (OR 1.57, 95% CI 1.15 to 2.16, p=0.005), kidney disease (OR 1.73, 95% CI 1.18 to 2.55, p=0.005) and congestive heart failure (OR 1.62, 95% CI 1.06 to 2.48, p=0.025). Mortality at 30 days was lower in patients with a preoperative diagnosis of SARS-CoV-2 (OR 0.6, 95% CI 0.6 (0.42 to 0.85), p=0.004). There was no difference in mortality in patients with an increase to delay in surgery (p=0.220) or type of anaesthetic given (p=0.787). Conclusions Patients undergoing surgery for a proximal femoral fracture with a perioperative infection of SARS-CoV-2 have a high rate of mortality. This study would support the need for providing these patients with individualised medical and anaesthetic care, including medical optimisation before theatre. Careful preoperative counselling is needed for those with a proximal femoral fracture and SARS-CoV-2, especially those in the highest risk groups. Trial registration number NCT0432364